
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [BMRN] BioMarin Pharmaceutical Inc
Data updated 2025-May-07 (Wednesday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab

Share
2025-May-07 Wednesday
Open | $59.96 | High | $60.16 +0.33% |
---|---|---|---|
Close | $59.32 | Low | $58.85 -1.85% |
Volume | 1.3 Million 1.15x | Volatility | 2.23% |
Change |
$-0.32
-0.54%
|
Streak | ↓ 2 days -4.42% |
20d SMA | $60.70 -2.3% | 50d SMA | $65.97 -10.1% | 100d SMA | $65.54 -9.5% | 200d SMA | $70.50 -15.9% |
RSI | 38 | MACD | 0.13 | ADX | 22.4 | Stochastic Oscillator | 31.6 47.5 |
CCI | -39.2 | ATR | 2.26 | OBV | 235 Million | Chaikin A/D | 170 Million |
Market Cap | 16.4 B | PEG Ratio | 0.72 | Trailing P/E | 99.9 | Forward P/E | 32.4 |
Price/Sales (ttm) | 6.88 | Price/Book (mrq) | 3.31 | EV/Revenue (ttm) | 6.78 | EV/EBITDA (ttm) | 53 |
% Held by Insiders | 0.69% | % Held by Institutions | 101.31% | Shares Short | 2.96 M | Shares Short (prior month) | 3.26 M |
Short Ratio | 1.94 | Short % of Outstanding | 1.57% | Short % of Float | 1.58% | Shares Short Change (mom) | -9.2% |
Revenue/Share (ttm) | $12.88 | Profit Margin (ttm) | 6.93% | Operating Margin (ttm) | 4.37% | EBITDA (ttm) | 276 M |
Diluted EPS (ttm) | $0.87 | Current Ratio (mrq) | 2.51 | Return on Assets (ttm) | 1.63% | Return on Equity (ttm) | 3.51% |
Qtr Earnings Growth (yoy) | Qtr Revenue Growth (yoy) | 20.20% | Operating Cash Flow (ttm) | 159 M | Free Cash Flow (ttm) | -25.9 M | |
Choose view type
Daily Performance for BioMarin Pharmaceutical Inc. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for BioMarin Pharmaceutical Inc up to close of 2025-May-07 at $59.32
3-month Performance Benchmarks for BioMarin Pharmaceutical Inc:
Related to BioMarin Pharmaceutical Inc
Information for BioMarin Pharmaceutical Inc
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-07 on Google
SEC Reports : Quarterly reports around 2025-May-07 on SEC Edgar
Compare BioMarin Pharmaceutical Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes BioMarin Pharmaceutical Inc
Industry : Biotechnology industry performance which includes BioMarin Pharmaceutical Inc